Efficient inhibition of emerging SARS-CoV-2 variants including NB.1.8.1, XFG and BA.3.2 by a fusion inhibitor HY3000 peptide

The Innovation Life 2026 Open access

Read full text

Authors: Wei Liu, Lili Wu, Jiajing Li, George F. Gao, Qihui Wang

DOI: 10.59717/j.xinn-life.2026.100184

Cited by: 0

References: 10

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Peptidase Inhibition and Analysis

References 10